Effects of salivary protein flow and indigenous microorganisms on initial colonization of Candida albicans in an in vivo model

BMC Oral Health

Volumn 12, Issue 1, 2012, Pages

  Kanaguchi, Norihiko ^a,c   Narisawa, Naoki ^c   Ito, Tatsuro ^b,c   Kinoshita, Yosuke ^a,c   Kusumoto, Yasuka ^a,c   Shinozuka, Osamu ^a   Senpuku, Hidenobu ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Candida albicans; Colonization; NOD SCID.e2f1 mice; Saliva; Sucrose

Indexed keywords

IMMUNOGLOBULIN G; SALIVA PROTEIN; SECRETORY IMMUNOGLOBULIN; SUCROSE;

ANIMAL; ARTICLE; BACTERIAL COUNT; BIOFILM; CANDIDA ALBICANS; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FEMALE; FUNGUS HYPHAE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MOUTH MUCOSA; NATURAL KILLER CELL; NONOBESE DIABETIC MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SALIVA; SECRETION (PROCESS); SECRETION RATE; THRUSH; TONGUE; XEROSTOMIA;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; HYPHAE; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; MICE; MICE, INBRED NOD; MICE, INBRED STRAINS; MICE, SCID; MOUTH MUCOSA; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SECRETORY RATE; SUCROSE; TONGUE; XEROSTOMIA;

EID: 84865532934     PISSN: None     EISSN: 14726831     Source Type: Journal    
DOI: 10.1186/1472-6831-12-36     Document Type: Article

References (54)

1. Douglass LJ. Candida biofilms and their role in infection. Trends Microbiol 2003, 11:30-36. 10.1016/S0966-842X(02)00002-1, 12526852.
2. Douglass LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol 2002, 19:139-143.
3. Kumamoto CA. Candida biofilms. Curr Opin Microbiol 2002, 5:608-611. 10.1016/S1369-5274(02)00371-5, 12457706.
4. Kawamura-Sato K, Wachino J, Kondo T, Ito H, Arakawa Y. Reduction of disinfectant bactericidal activities in clinically isolated Actinetobacter species in the presence of organic material. J Antimicrob Chemother 2008, 61:568-576. 10.1093/jac/dkm498, 18192683.
5. Lopez-Ribot JL, McAtee RK, Perea S, Kirkpatrick WP, Rinalci MG, Petterson TF. Multiple resistance phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1999, 43:1621-1630. 89334, 10390213.
6. Mukherjee PK, Clandra J. Candida biofilm resistance. Drug Resist Updat 2004, 7:301-309. 10.1016/j.drup.2004.09.002, 15533767.
7. Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 2001, 20:42-44.
8. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003, 3:685-702. 10.1016/S1473-3099(03)00801-6, 14592598.
9. Bailli GS, Douglas LJ. Matrix polymers of Candida biofilmsand their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000, 46:397-403. 10.1093/jac/46.3.397, 10980166.
10. Donlan RM, Costerton JW. Bioiofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193. 10.1128/CMR.15.2.167-193.2002, 118068, 11932229.
11. Kumamoto CA, Vinces MD. Alternative Candida albicans lifestyles: growth on surfaces. Annu Rev Microbiol 2005, 59:113-133. 10.1146/annurev.micro.59.030804.121034, 16153165.
12. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007, 51:510-520. 10.1128/AAC.01056-06, 1797745, 17130296.
13. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System. Am J Cardiol 1998, 82:789-793. 10.1016/S0002-9149(98)00450-0, 9761092.
14. Reichart PA, Philipsen HP, Schmidt-Westhausen A, Samaranayake LP. Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings. J Oral Pathol Med 1995, 24:268-281.
15. de Repentigny L, Lewandowski D, Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 2004, 17:729-759. 10.1128/CMR.17.4.729-759.2004, 523562, 15489345.
16. Fu Y, Rieg G, Fonzi WA, Belanger PH, Edwards JE, Filler SG. Expression of the Candida albicans gene ALSI in Saccharomyces cerevisiae induces adherence to endothelial cells. Infect Immun 1998, 66:1783-1786. 108121, 9529114.
17. McDonnell GE. Antisepsis, Disinfection, and sterilization; types, action, and resistance 2007, Washington, DC: AZM press.
18. Sandovsky-Losica H, Chauhan N, Calderone R, Segal E. Gene transcription studies of Candida albicans following infection of HEp2 epithelial cells. Med Mycol 2006, 44:329-334. 10.1080/13693780500434701, 16772226.
19. Cawson RA, Rajasingham KC. Ultrastructural features of the invasive phase of Candida albicans. Br J Dermatol 1972, 87:435-443. 10.1111/j.1365-2133.1972.tb01591.x, 4567096.
20. Eversole LR, Reichart PA, Ficarra G, Schimidt-Westhausen A, Romagnoli P, Pimpinelli N. Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 1997, 84:372-380.
21. Kamai Y, Kobota M, Hosokawa T, Fukuoka T, Filler SG. New model of oropharyngeal candidiasis in mice. Antimicrob Agents Chemother 2001, 45:3195-3197. 10.1128/AAC.45.11.3195-3197.2001, 90803, 11600377.
22. Montes LF, Wilbom WH. Ultrastructural features of host-parasite relationship in oral candidiasis. J Bacteriol 1986, 96:1349-1356.
23. Matsui-Inohara H, Uematsu H, Narita T, Satoh K, Yonezawa H, Kuroda K, Ito T, Yoneda S, Kawarai T, Sugiya H, Watanabe H, Senpuku H. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production. Exp Biol Med 2009, 234:1519-1524.
24. Ito T, Maeda T, Senpuku H. Roles of salivary components in Streptococcus mutans colonization in a new animal model using NOD/SCID.e2f1-/- mice. PLoS One in press.
25. Naglik JR, Fidel PL, Odds FC. Animal models of mucosal Candida infection. FEMS Microbiol Lett 2008, 283:129-139. 10.1111/j.1574-6968.2008.01160.x, 3244615, 18422625.
26. de Repentigny L. Animal models in the analysis of Candida host-pathogen interactions. Curr Opin Microbiol 2004, 7:324-329. 10.1016/j.mib.2004.06.001, 15288620.
27. Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernández-Santos N, Edgerton M, Gaffen SL, Lenardo MJ. Cell: CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011, 34:422-434. 10.1016/j.immuni.2011.03.002, 3258585, 21435589.
28. Matsumoto N, Salam MA, Watanabe H, Amagasa T, Senpuku H. Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice. Oral Microbiol Immunol 2004, 19:270-276. 10.1111/j.1399-302X.2004.00151.x, 15209999.
29. Senpuku H, Matin K, Salam MA, Kurauchi I, Sakurai S, Kawashima M, Murata T, Miyazaki H, Hanada N. Inhibitory effects of MoAbs against a surface protein antigen in real-time adherence in vitro and recolonization in vivo of Streptococcus mutans. Scand J Immunol 2001, 54:109-116. 10.1046/j.1365-3083.2001.00962.x, 11439156.
30. Salam MA, Matsumoto N, Matin K, Tsuha Y, Nakao R, Hanada N, Senpuku H. Clin Diagn Lab Immunol 2004, 11:379-386. 371204, 15013991.
31. Cannon RD, Nand AK, Jenkinson HF. Adherence of Candida albicans to human salivary components adsorbed to hydroxylapatite. Microbiology 1995, 141:213-219. 10.1099/00221287-141-1-213, 7894715.
32. Nikawa H, Nishimura H, Hamada T, Yamashiro H, Samaranayake LP. Effects of modified pellicles on Candida biofilm formation on acrylic surfaces. Mycoses 1999, 42:37-40. 10.1046/j.1439-0507.1999.00270.x, 10865902.
33. Nikawa H, Nishimura H, Makihira S, Hamada T, Sadamori S, Samaranayake LP. Effect of serum concentration on Candida biofilm formation on acrylic surfaces. Mycoses 2000, 43:139-143. 10.1046/j.1439-0507.2000.00564.x, 10907344.
34. Tobgi RS, Samaranayake LP, MacFarlane TW. In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 1988, 3:35-39. 10.1111/j.1399-302X.1988.tb00603.x, 3268748.
35. Xu T, Levitz SM, Diamond RD, Oppenheim FG. Anticandidal activity of major human salivary histatins. Infect Immun 1991, 59:2549-2554. 258054, 1855975.
36. Nikawa H, Samaranayake LP, Tenovuo J, Pang KM, Hamada T. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Arch Oral Biol 1993, 38:1057-1063. 10.1016/0003-9969(93)90167-K, 8141667.
37. Müller F, Frøland SS, Brandtzaeg P, Fagerhol MK. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin Infect Dis 1993, 16:301-302. 10.1093/clind/16.2.301, 8443314.
38. Challacombe SJ. Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 1994, 78:202-210. 10.1016/0030-4220(94)90148-1, 7936590.
39. Samaranayake YH, MacFarlane TW, Samaranayake LP, Aitchison TC. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media. J Nat Prod 1992, 55:1648-1654. 10.1021/np50089a014, 1479381.
40. Cantorna MT, Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 1990, 58:1093-1100. 258587, 2180820.
41. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411. 10.1038/375408a0, 7539113.
42. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A 2002, 99:2129-2133. 10.1073/pnas.042692699, 122330, 11854508.
43. Liljemark WF, Gibbons RJ. Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect Immun 1973, 8:846-849. 422937, 4584056.
44. Müller G, Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrobial Chemother 2008, 61:1281-1287.
45. Sanchez IR, Nusbaum KE, Swaim SF, Hale AS, Henderson RA, McGuire JA. Chlorhexidine diacetate and povidone-iodine cytotoxicity to canine embryonic fibroblasts. Staphylococcus aureus 1988, 17:182-185.
46. Grubb SE, Murdoch C, Sudbery PE, Saville SP, Lopez-Ribot JL, Thornhill MH. Adhesion of Candida albicans to endothelial cells under physiological conditions of flow. Infect Immun 2009, 77:3872-3878. 10.1128/IAI.00518-09, 2738003, 19581400.
47. Braun BR, Johnson AD. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 1997, 277:105-109. 10.1126/science.277.5322.105, 9204892.
48. Braun BR, Head WS, Wang MX, Johnson AD. Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics 2000, 156:31-44. 1461230, 10978273.
49. Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, Schnell N, Talibi D, Marechal D, Tekaia F, d'Enfert C, Gaillardin C, Odds FC, Brown AJ. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 2001, 20:4742-4752. 10.1093/emboj/20.17.4742, 125592, 11532938.
50. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003, 2:1053-1060. 10.1128/EC.2.5.1053-1060.2003, 219382, 14555488.
51. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF. Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect Immun 2010, 78:4644-4652. 10.1128/IAI.00685-10, 2976310, 20805332.
52. Cannon RD, Chaffin WL. Oral colonization by Candida albicans. Crit Rev Oral Biol Med 1999, 10:359-383. 10.1177/10454411990100030701, 10759414.
53. Jabra-Rizk MA, Falkler WA, Merz WG, Kelley JI, Baqui AA, Meiller TF. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J Clin Microbiol 1999, 37:1464-1468. 84803, 10203506.
54. Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev 1998, 62:130-180. 98909, 9529890.